DVAX
Dynavax Technologies Corp
Price:  
12.76 
USD
Volume:  
1,489,835.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVAX Relative Valuation

-109.2%
Upside

As of 2024-03-03, the Relative Valuation of Dynavax Technologies Corp (DVAX) is (1.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.76 USD, the upside of Dynavax Technologies Corp based on Relative Valuation is -109.2%.

The range of the Relative Valuation is (1.09) - (1.31) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 22.4x - 27.3x 24.8x
Forward P/E multiples 19.7x - 26.8x 23.2x
Fair Price (1.09) - (1.31) (1.17)
Upside -108.6% - -110.3% -109.2%
12.76 USD
Stock Price
(1.17) USD
Fair Price

DVAX Relative Valuation - Historical P/E Data

Date P/E
2024-03-01 -261.18
2024-02-29 -259.34
2024-02-28 -265.07
2024-02-27 -265.89
2024-02-26 -268.96
2024-02-23 -260.97
2024-02-22 -254.63
2024-02-21 -255.04
2024-02-20 -251.35
2024-02-16 -254.02
2024-02-15 -255.45
2024-02-14 -255.45
2024-02-13 -251.56
2024-02-12 -262.41
2024-02-09 -264.45
2024-02-08 -263.64
2024-02-07 -264.04
2024-02-06 -265.68
2024-02-05 -261.79
2024-02-02 -260.97
2024-02-01 -261.59
2024-01-31 -264.45
2024-01-30 -266.91
2024-01-29 -274.28
2024-01-26 -272.64
2024-01-25 -281.44
2024-01-24 -285.33
2024-01-23 -291.88
2024-01-22 -290.24
2024-01-19 -285.54
2024-01-18 -285.95
2024-01-17 -286.36
2024-01-16 -290.24
2024-01-12 -285.13
2024-01-11 -284.31
2024-01-10 -282.67
2024-01-09 -284.72
2024-01-08 -285.95
2024-01-05 -301.71
2024-01-04 -306.62
2024-01-03 -295.16
2024-01-02 -294.34
2023-12-29 -286.15
2023-12-28 -291.27
2023-12-27 -289.22
2023-12-26 -287.17
2023-12-22 -283.29
2023-12-21 -278.78
2023-12-20 -271.41
2023-12-19 -283.08